Navigation Links
Clinically Relevant Technologies Releases New Medical iPhone App To Fill Gap In Adherence To Low Back Pain Management Guidelines
Date:3/2/2010

Clinically Relevant Technologies counts on the iPhone to fill the gap in poor physician adherence to low back pain management guidelines with the release of new medical iPhone app.

(PRWEB) March 2, 2010 -- Clinically Relevant Technologies released a new medical iphone app for the iPhone platform this week to help bridge an expensive health care gap. The release comes on the heels of a study published last month in the Archives of Internal Medicine that showed general practioners are not following guidelines for effective management of low back pain. The study concluded that this "unendorsed care may contribute to the high costs of managing LBP, and some aspects of the care provided carry a higher risk of adverse effects."

Low back pain is one of the most common generators of health care visits and its reported that at least 25% of Americans have had an episode of back pain that lasts at least a full day within the last 3 months. This is not without significant cost as over $25 billion are reportedly spent each year managing low back pain, and 2% of the entire U.S. workforce receives compensation for low back pain each year (Chou, Annals of Internal Medicine, 2007). These guidelines can be followed with no increase in risk for the patient while at the same time providing even better clinical outcomes and reduced costs according to another study (Fritz, Medical Care, 2007).

Clinically Relevant Technologies aims to bridge this gap by providing point-of-care information to clinicians with the new Low Back Pain Management Guidelines medical application for the iPhone™. Clinicians can now access interactive information for screening, diagnosis, and interventions based on the American College of Physicians and American Pain Society's published guidelines.

About Clinically Relevant Technologies (CRTech, LLC)
CRTech, LLC (clinicallyrelevant.com) ) is a small company comprised of full-time clinicians and researchers that believe in promoting a climate of evidence-guided decision-making in medical practice that is clinically relevant, through the use of smartphones and mobile devices. CRTech also developed the popular medical application CORE - Clinical ORthopaedic Exam, an evidence-based clinical diagnostic tool for management of musculoskeletal pathology, for both the iPhone™ and the Android™ platforms.

Android is a trademark of Google, Inc. iPhone is a trademark of Apple, Inc. PUBMed is a service of the National Library of Medicine and the National Institutes of Health. Clinically Relevant Technologies is in no way affiliated with the American College of Physicians or American Pain Society.

###

Read the full story at http://www.prweb.com/releases/medical/iphone/prweb3665234.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Rest Assured With Clinically Tested Anti-Snore Pillow
2. HOWARU(R) Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children
3. YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System.
4. Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings
5. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
6. Side discrepancy errors in radiology reports rare but often clinically significant
7. Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus
8. Physician and Author to Share Clinically Proven System for Permanent Weight Loss and Optimal Health in Westerville and Dublin, Ohio Areas
9. PlumSmart Plum Juice Clinically Proven to Help Regulate Digestion, Naturally
10. A Clinically Proven, Extremely Effective and Safe Product for Joints Now Available
11. Commonly used beauty staple clinically proven to help treat eczema
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinically Relevant Technologies Releases New Medical iPhone App To Fill Gap In Adherence To Low Back Pain Management Guidelines
(Date:9/22/2017)... , ... September 22, 2017 , ... ... nutritional supplement produced by Native Remedies that helps promote pancreatic health and ... many individuals. However, some prescription-based approaches can have negative side effects, and with ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving compilation ... have value to God. “Letters From Home” is the creation of published author, John ... President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on four ...
(Date:9/21/2017)... ... ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery Center is Saluted as Young ... Plastic Surgeon Kiranjeet Gill has been awarded as one of the 15th annual 40-under-40 ... was started in 2003 to salute young achievers in Southwest Florida who have distinguished ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... a new member survey conducted by the International Society of Hair Restoration ... 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... OrthoAtlanta has been named the official orthopedic and sports ... the 2018 College Football Playoff (CFP) National Championship to be ... Atlanta, Georgia . OrthoAtlanta is proud to ... in many activities leading up to, and including the national ... OrthoAtlanta ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology: